Delivery Order SPE2DB22D3016-SPE2DB24FASH8
- Not listed
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of pharmaceutical products, including the drug TIVDAK 40 MG VIALS. The award has a ceiling value of $27,898.01 and a completion date of November 13, 2024. The contract is a Delivery Order under a Firm Fixed Price pricing type, with no set-aside designation. AmerisourceBergen, a major pharmaceutical distributor, holds a significant Indefinite Delivery Contract (IDC) with...
- This is a $13,083.75 firm fixed-price delivery order awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The contract is for the delivery of TIVDAK 40 MG vials, with a performance period through July 2025. The contract is not set aside for a specific business type. Amerisourcebergen Drug Corp holds a significant $999,999,999.00 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which provides a comprehensive...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of TIVDAK 40 MG VIALS, a pharmaceutical product, with a firm fixed price of $13,083.75 and a completion date of April 23, 2025. The contract is not set-aside and represents open competition. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the...
- This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract, valued at $13,083.75, is for the supply of 4,567,926,049 units of the drug TIVDAK 40 MG VIALS. The contract has an ultimate completion date of May 6, 2025. AmerisourceBergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999.00, which provides a...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. The $5,994.80 firm fixed price delivery order is for the supply of 4563968987 TDVAX VIAL 0.5ML pharmaceutical products. This award is associated with a larger $999,999,999.00 indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp as the prime...
- This federal contract award to Amerisourcebergen Drug Corp (a major pharmaceutical distributor and healthcare solutions provider) was issued by the Defense Logistics Agency (DLA) Troop Support Medical. The $4,173.10 firm-fixed-price delivery order has an ultimate completion date of October 30, 2024. This award is a part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA, which serves as a primary vehicle for providing a comprehensive range of...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a ceiling value of $16,554.44 and a firm fixed price pricing type. The ultimate completion date is June 17, 2025. This award is not associated with a set-aside program. Amerisourcebergen Drug Corp has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $11,813.76 delivery order contract has a firm fixed price pricing type and a completion date of December 3, 2024. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
- This federal contract award, valued at $11,397.30, was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The delivery order contract is for a firm fixed price, with an ultimate completion date of April 29, 2025. The contract is not designated as a set-aside. Amerisourcebergen Drug Corp holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $16,844.28 firm fixed-price delivery order covers a variety of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits. The contract has an ultimate completion date of November 25, 2024....
- SPE2DB22D3016Indefinite Delivery Contract
- SPE2DB22D3016-SPE2DB24FASH8Delivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The $11,956.29 firm fixed price delivery order is for the supply of 40 mg vials of the drug TIVDAK. The award has an ultimate completion date of May 2, 2024. Amerisourcebergen Drug Corp holds an indefinite delivery contract (IDC) with DLA valued up to $999,999,999.00, which serves as the primary vehicle for the company to deliver pharmaceutical products and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This specific delivery order was issued under that IDC. The contract does not include any set-aside designations.